• Home
  • Conference Highlights
    • View All Conference Highlights
  • Year in Review / Wrap-Ups
    • Wrap-Ups
    • Year in Review
  • Contact Us
  • Articles

Articles

Concurrent Treatment of Advanced Melanoma with Ipilimumab and Nivolumab
ASCO 2014 – Immuno-Oncology
Read More ›

Ipilimumab for Initial Treatment of Metastatic Uveal Melanoma
ASCO 2014 – Immuno-Oncology
Read More ›

Nivolumab Combined with Ipilimumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
Read More ›

Adjuvant Ipilimumab for Patients with High-Risk Melanoma
ASCO 2014 – Immuno-Oncology
Read More ›

First Trial Assessing Nivolumab in Platinum-Resistant Ovarian Cancer
ASCO 2014 – Immuno-Oncology
Read More ›

Page 147 of 147

  • 144
  • 145
  • 146
  • 147
  • Home
  • Conference Highlights
    • View All Conference Highlights
  • Year in Review / Wrap-Ups
    • Wrap-Ups
    • Year in Review
  • Contact Us


© Amplity, Inc. All Rights Reserved. Privacy Policy